$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
埃索美拉唑能不能治疗胃痛
2025-10-19 11:44:20
Check Details
埃索美拉唑胃炎病人能用吗
2025-10-19 11:44:20
Check Details
耐信(埃索美拉唑)多少钱
2025-10-19 11:44:20
Check Details
耐信(埃索美拉唑)国内有吗
2025-10-19 11:44:20
Check Details
耐信(埃索美拉唑)好吗
2025-10-19 11:44:20
Check Details
耐信(埃索美拉唑)好用吗
2025-10-19 11:44:20
Check Details
耐信(埃索美拉唑)和雷贝拉唑及奥美拉唑的区别
2025-10-19 11:44:20
Check Details
耐信(埃索美拉唑)效果比奥美拉唑好吗
2025-10-19 11:44:20
Check Details
耐信(埃索美拉唑)效果好吗
2025-10-19 11:44:20
Check Details
耐信(埃索美拉唑)和雷贝拉唑有那些不同
2025-10-19 11:44:20
Check Details
耐信(埃索美拉唑)与奥美拉唑的区别?哪个好
2025-10-19 11:44:20
Check Details
耐信(埃索美拉唑)价格多少
2025-10-19 11:44:20
Check Details
1
2
...
3879
3880
3881
3882
3883
3884
3885
...
10230
10231
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Finerenone: Indications, Dosing Strategy, and Combination Therapy
2
Selpercatinib: Dosing and Administration Essentials of an Oral RET Inhibitor
3
Enasidenib: A Targeted IDH2 Inhibitor for Acute Myeloid Leukemia
4
Alpelisib: From Breast Cancer to PIK3CA-Related Overgrowth Spectrum
5
Ponatinib in Chronic Myeloid Leukemia: 5-Year Results from the OPTIC Trial
6
Erdafitinib Oral Tablets: Strengths, Packaging, and Dose Adjustment
7
Capmatinib (Tabrecta): Oral Targeted Therapy for MET Exon 14 Skipping-Mutated NSCLC
8
Amivantamab Plus Lazertinib: A Chemotherapy-Free First-Line Option in EGFR-Mutated NSCLC
9
Midostaurin (Rydapt): Dosing Essentials in FLT3-Mutated AML and Systemic Mastocytosis
10
Lapatinib: An Oral Dual EGFR/HER2 TKI in HER2-Positive Breast Cancer
11
Filgotinib (Jyseleca) Overseas Guide: JAK1 Inhibitor for Rheumatoid Arthritis and Ulcerative Colitis
12
FDA Approves LISRAYA (brepocitinib): First Oral Targeted Therapy for Adults with Dermatomyositis